Vehicle cream (same formulation of cream as the test product but without active substance)
Sponsors
Incyte Corp.
Conditions
Prurigo Nodularis
Phase 3
INCB 18424-319: A phase 3, double-blind, randomised, vehicle-controlled, efficacy and safety study of ruxolitinib cream in participants with Purigo Nodularis.
Topical ruxolitinib evaluation in Prurigo Nodularis (TRuE-PN1)
CompletedCTIS2022-501621-20-00
Start: 2023-10-02End: 2025-04-23Target: 68Updated: 2025-04-28
INCB 18424-320: A phase 3, double-blind, randomised, vehicle-controlled, efficacy and safety study of ruxolitinib cream in participants with Prurigo Nodularis.
Topical ruxolitinib evaluation in Prurigo Nodularis (TRuE-PN2)
CompletedCTIS2022-502461-23-00
Start: 2024-02-15End: 2025-11-04Target: 117Updated: 2025-07-10